Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
342
archived clinical trials in
Restless Leg Syndrome

Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
mi
from
Orange, CA
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
mi
from
Orange, CA
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
mi
from
Spring Hill, FL
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
mi
from
Spring Hill, FL
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated:  2/9/2016
Clinical Research Facility
mi
from
Destrehan, LA
Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome
An Open-Label, Long-Term, Follow-Up Study To Determine The Safety, Tolerability, and Efficacy of Rotigotine Transdermal System As Monotherapy in Adolescents With Restless Legs Syndrome
Status: Enrolling
Updated: 2/9/2016
Clinical Research Facility
mi
from
Destrehan, LA
Click here to add this to my saved trials
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Status: Enrolling
Updated:  2/23/2016
Yale Physcian Building
mi
from
New Haven, CT
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.
Status: Enrolling
Updated: 2/23/2016
Yale Physcian Building
mi
from
New Haven, CT
Click here to add this to my saved trials
Sleep Disorders Management, Health and Safety in Police
Sleep Disorders Management, Health and Safety in Police
Status: Enrolling
Updated:  3/15/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Sleep Disorders Management, Health and Safety in Police
Sleep Disorders Management, Health and Safety in Police
Status: Enrolling
Updated: 3/15/2016
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Status: Enrolling
Updated:  3/15/2016
Division of Sleep Medicine; Brigham and Women's Hospital
mi
from
Boston, MA
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Status: Enrolling
Updated: 3/15/2016
Division of Sleep Medicine; Brigham and Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Status: Enrolling
Updated:  6/28/2016
University of South Florida
mi
from
Tampa, FL
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Status: Enrolling
Updated: 6/28/2016
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) in Subjects With Restless Legs Syndrome
Status: Enrolling
Updated:  7/12/2016
Kyowa Pharmaceutical Inc.
mi
from
Princeton, NJ
Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome
A Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of 40mg/Day KW-6002 (Istradefylline) in Subjects With Restless Legs Syndrome
Status: Enrolling
Updated: 7/12/2016
Kyowa Pharmaceutical Inc.
mi
from
Princeton, NJ
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Birmingham, AL
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Mesa, AZ
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Phoenix, AZ
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Sun City, AZ
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Sun City, AZ
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Anaheim, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Burlingame, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Burlingame, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Long Beach, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Newport Beach, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Pasadena, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Pasadena, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Redondo Beach, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Santa Monica, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Santa Monica, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Stanford, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Stanford, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Winnetka, CA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Winnetka, CA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Boca Raton, FL
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Boca Raton, FL
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Coeur d'Alene, ID
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Springfield, MA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Springfield, MA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
West Yarmouth, MA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
West Yarmouth, MA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Worcester, MA
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Kalamazoo, MI
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
St. Paul, MN
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
St. Paul, MN
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
St. Louis, MO
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Las Vegas, NV
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Las Vegas, NV
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Albany, NY
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Albany, NY
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Tabor City, NC
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Tabor City, NC
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Fargo, ND
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Fargo, ND
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Warwick, RI
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Warwick, RI
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Burlington, VT
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Burlington, VT
Click here to add this to my saved trials
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/17/2016
GSK Investigational Site
mi
from
Camperdown,
RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
A 12-Week, Randomized, Double-Blind, Parallel Group, Multicentre Study to Assess the Tolerability and Clinical Benefits of Ropinirole Extended Release (XR) Tablets Compared With Ropinirole Immediate Release (IR) Tablets in Subjects With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/17/2016
GSK Investigational Site
mi
from
Camperdown,
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Alabaster, AL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Alabaster, AL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Jasper, AL
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Jasper, AL
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Mesa, AZ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Mesa, AZ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Sun City, AZ
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Sun City, AZ
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Laguna Hills, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Northridge, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Northridge, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Oxnard, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Oxnard, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Pasadena, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Pasadena, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Redondo Beach, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Redondo Beach, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
Reseda, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
Reseda, CA
Click here to add this to my saved trials
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated:  10/27/2016
GSK Investigational Site
mi
from
San Diego, CA
Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
A 52-Week, Open-Label Study to Assess the Long-Term Safety of Ropinirole Extended Release (XR) in Patients With Restless Legs Syndrome (RLS)
Status: Enrolling
Updated: 10/27/2016
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials